Most men starting testosterone therapy do not know what is actually in the syringe. They are told they will be on TRT, they get a script, they go home and inject. They do not know whether they are getting cypionate, a different ester, or a compounded blend — and most providers never explain the difference.
That is a problem.
Different testosterone esters have different release profiles. They produce slightly different lab patterns. They are dosed on different cadences. The protocol that works on one ester may not transfer cleanly to another. This is not academic — it shows up in how patients feel week to week.
In my practice I run testosterone cypionate exclusively. This article explains why, and why you should ask any TRT provider exactly what they are putting in your syringe before you start.
What testosterone cypionate is
Cypionate is testosterone bound to a fatty acid called cypionic acid. The fatty acid does not change what the testosterone does once it is released — testosterone is testosterone — but it controls the rate at which the molecule is released from the injection site into the bloodstream. The longer and more lipid-soluble the fatty acid chain, the slower the release.
Cypionate has a half-life of approximately 8 days. That means after a single injection, half of the dose has been released and metabolized in about a week. Practically, this is what allows weekly dosing to produce a smooth, stable testosterone curve — by the time the previous week's dose is half-cleared, the next dose is going in.
It is delivered as an oil-based solution, almost always intramuscularly into the gluteal or thigh muscle, or subcutaneously into the abdomen or thigh. Both routes work. I cover the technique in detail in my self-injection guide.
Why I standardized on cypionate
There are three real reasons.
One. Clinical consistency. Standardizing on a single ester means every patient on injection therapy in my practice is being measured against the same kinetic baseline. When I see a lab pattern I do not like — total T running too high, free T not where I want it, hematocrit creeping — I know exactly how cypionate behaves and exactly what dose adjustment will produce the response I want. If I were running multiple esters in parallel, every adjustment would require re-thinking which kinetic profile I was working against. That introduces error I do not need.
Two. Supply and reliability. Cypionate is the most commonly stocked testosterone ester in US pharmacy supply chains. That matters when a patient calls me to say their pharmacy is on backorder, or when an insurance company changes its formulary, or when a patient travels and needs to pick up a fill in another state. With cypionate, those problems are usually solvable in a single phone call. With less common esters, sometimes they are not.
Three. Patient outcomes I have observed. Across the men I have treated with injection-based TRT, weekly cypionate produces the smoothest symptom profile. The peak-and-trough fluctuation is real but minimal at a sensible dose. Patients report stable energy and mood through the week — not a mid-week dip. The labs look the way I want them to look, and the way they feel matches what the labs say. That is the bar.
What you should ask any TRT provider before starting
This is the part most patients miss. Before you start injection therapy with anyone, ask three questions:
1. What ester are you prescribing me, and why that one?
If the provider cannot answer the "why" — if it is just "this is what we use" — that is a yellow flag. Not necessarily disqualifying, but an indicator the provider may not be calibrated tightly to a specific ester's behavior.
Have questions about your TRT protocol?
Bring your labs and your questions. We will walk through the protocol that fits your physiology — including which delivery method makes the most sense for you and why.
Book a TRT Consultation2. What is my injection cadence and dose, and how was that calculated?
A real protocol is built from your baseline labs, your symptoms, your weight and body composition, and your goals. If the answer is "everyone here starts at X mg weekly," that is a one-size-fits-all approach. Sometimes that works. Often it does not.
3. When will we recheck labs and what specifically are we measuring?
The right answer involves total testosterone, free testosterone, SHBG, estradiol, hematocrit, PSA, and a metabolic panel — drawn at the 8-12 week mark and at intervals appropriate to the protocol. If the provider is only checking total T, that is incomplete. Total T alone tells you almost nothing about how the patient is going to feel.
The cypionate dose conversation
I do not publish dose ranges in print. The reason is simple: a dose number out of context invites self-comparison. A man reads "Travis starts most patients at X mg weekly" and assumes that means he should be at X mg weekly too — without context for his SHBG, his free T, his body weight, or his individual response curve.
Here is what I will say. Doses in my practice are individualized. The starting dose comes from your baseline labs and your clinical picture. The first reassessment at 8-12 weeks tells us whether the dose is right, too high, or too low. We adjust from there. By cycle two or three, most patients are running at a stable maintenance dose that fits their physiology — and the labs and the symptoms agree.
That is the work. The number on the syringe is the smallest part of it.
Why this matters for cypionate specifically
Standardizing on cypionate is not the only way to practice. There are excellent providers who run different esters or use compounded blends. The point is not that one ester is right and others are wrong.
The point is that picking an ester is a clinical decision that should be made deliberately, communicated to the patient, and not changed without reason. When you start injection therapy with me, you know exactly what you are getting and why. You know it is cypionate. You know how it behaves. You know the cadence. You know what we will check and when.
That clarity is the protocol. The molecule is just the molecule.
What this looks like in practice
If you are evaluating injection-based TRT, the consultation walks through:
- Your baseline lab panel — total T, free T, SHBG, estradiol, DHEA, PSA, CBC, full metabolic markers
- Your symptom history and goals
- The cypionate dose I would recommend and why, with route and cadence specified
- The reassessment timeline and exactly what we will recheck
- The expected response curve — what to expect at week 2, week 4, week 8, week 12
- An honest conversation about whether injection therapy is the right delivery method for you, or whether Biote pellet therapy would be a better fit given your physiology
The choice between injections and pellets is a real one and I run both. If you are still figuring out which makes more sense for you, the pellets vs injections breakdown lays out the decision framework I use with patients.
If you are already on injections elsewhere and curious about switching providers — bring your last six months of labs to the consultation. That conversation usually goes faster than you expect.
Medical disclaimer: This article is educational and does not constitute medical advice. Testosterone replacement therapy requires comprehensive lab work, in-person clinical evaluation, and ongoing monitoring. Individual responses vary. Not all patients are candidates for TRT. Discuss any treatment with your treating clinician.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
